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Market Report
Yr 
Ago
4 Wks
Ago 11/14/08
Livestock and Products,
 Weekly Average
Nebraska Slaughter Steers,
  35-65% Choice, Live Weight. . . . . . . . .
Nebraska Feeder Steers, 
  Med. & Large Frame, 550-600 lb.. . . . .
Nebraska Feeder Steers,
  Med. & Large Frame 750-800 lb. . . . . .
Choice Boxed Beef, 
  600-750 lb. Carcass. . . . . . . . . . . . . . .
Western Corn Belt Base Hog Price
  Carcass, Negotiated. . . . . . . . . . . . . . .
Feeder Pigs, National Direct
  50 lbs, FOB.. . . . . . . . . . . . . . . . . . . . .
Pork Carcass Cutout, 185 lb. Carcass,     
     51-52% Lean. . . . . . . . . . . . . . . . . . .
Slaughter Lambs, Ch. & Pr., Heavy,
  Wooled, South Dakota, Direct. . . . . . . .
National Carcass Lamb Cutout,
  FOB. . . . . . . . . . . . . . . . . . . . . . . . . . .
$93.15
118.26
113.24
143.50
45.91
34.81
59.15
91.00
266.75
$88.82
108.57
105.70
147.45
60.69
41.90
65.99
93.25
265.89
$91.76
107.72
102.85
155.68
51.73
54.45
57.28
97.62
265.39
Crops, 
 Daily Spot Prices
Wheat, No. 1, H.W.
  Imperial, bu. . . . . . . . . . . . . . . . . . . . . .
Corn, No. 2, Yellow
  Omaha, bu. . . . . . . . . . . . . . . . . . . . . .
Soybeans, No. 1, Yellow
  Omaha, bu. . . . . . . . . . . . . . . . . . . . . .
Grain Sorghum, No. 2, Yellow
  Dorchester, cwt. . . . . . . . . . . . . . . . . . .
Oats, No. 2, Heavy
  Minneapolis, MN , bu. . . . . . . . . . . . . .
7.00
3.64
10.06
6.59
2.79
5.00
3.93
8.54
5.32
      *
5.16
3.75
8.83
4.91
2.10
Feed
Alfalfa, Large Square Bales, 
  Good to Premium, RFV 160-185
  Northeast Nebraska, ton. . . . . . . . . . . .
Alfalfa, Large Rounds, Good
  Platte Valley, ton. . . . . . . . . . . . . . . . . .
Grass Hay, Large Rounds, Premium
  Nebraska, ton. . . . . . . . . . . . . . . . . . . .
Dried Distillers Grains, 10% Moisture, 
  Nebraska Average. . . . . . . . . . . . . . . .
Wet Distillers Grains, 65-70% Moisture,   
  Nebraska Average. . . . . . . . . . . . . . . .
135.00
87.50
       *
138.50
45.00
190.00
77.50
85.00
146.00
54.00
202.50
77.50
75.00
138.50
48.00
*No Market
The unexpected (to many) consumer resistance to the
first generation genetically modified (GM) food products
that focused on producers, and aimed at increasing yields,
hurt the prospects of the agricultural biotechnology sector.
As a response and in an effort to win back skeptical
consumers, agricultural biotechnology firms started
working on food products with functional properties
desirable to consumers, that are commonly known as
second generation GM products. Food products in this
category include vitamin A enriched rice and maize (golden
rice and golden maize), high protein wheat, and high oleic
soybean oil, to name a few. Recently, a new generation of
genetically engineered foods, referred to as genetically
engineered nutraceuticals has emerged, attracting a lot of
attention and stirring up additional controversy. While
many of the second generation, consumer oriented GM
food products can be viewed as genetically engineered
nutraceuticals, this latter category is much broader.    
The term nutraceuticals, a combination of the words
“nutrition” and “pharmaceutical,” was quoted by Dr.
Stephen DeFelice in 1989, who defined them as foods or
parts of foods that provided medicinal or health benefits to
consumers, including the prevention and treatment of`
diseases (Kalra 2003). The Nutraceuticals Institute
references nutraceuticals as phytochemicals or functional
foods that are natural, bioactive chemical compounds that
have health promoting, disease preventing or medicinal
properties (The Nutraceuticals Institute 2006). Recently,
the boundaries of what constitutes a nutraceutical have
expanded to include genetically engineered nutraceuticals
which are designed, according to the firms introducing
them, for the purpose of creating inexpensive alternative
pharmaceuticals, fighting disease in developing countries
and improving consumer health through common foods
such as fruits and vegetables. Thus, genetically engineered
nutraceuticals include foods which the direct consumption
of is associated with increased health benefits and/or
disease prevention (second generation GM food products),
but also foods, plants and animal products that will be
used to create vaccines and drugs that could treat or cure
a disease (third generation GM products). 
Examples of research currently conducted in this area
include research on genetically engineered bananas that
could be used for a Hepatitis B vaccine (Cosby 2007),
genetically engineered rice that will be used for a cholera
vaccine (Natarajan 2007), a genetically engineered chicory
plant to produce an anti-malaria medicine – the plant is
native to Africa where the medicine is mostly needed
(Plant Research International 2007), and a genetically
engineered version of the tobacco plant that could be used
in a vaccine for the human papillomavirus (HPV) or
cervical cancer (Perry 2007). The development of other
vaccines derived from genetically modified mushrooms
(EurekAlert 2007), algae (Bowen 2007) and livestock
(Svoboda 2007) is also under way. 
While most of these products are still in the
development stage, there are some that are closer to being
commercialized. A study conducted in Kansas tested a rice
variety genetically engineered to produce anti-diarrhea
medicine for children. The gene modified in the rice has
properties copied from a specific protein found in human
breast milk. The production of this protein will aid in the
fight against diarrhea in young children, which is currently
the second leading cause of infant and small child
mortality (Haarlander 2007). Ventria Bioscience plans to
launch this as an over-the-counter product by the end of
the year (Downing 2008). Another genetically engineered
nutraceutical that is close to its commercialization stage is
insulin production from dairy cow milk. This project is
being conducted in Argentina and the process involves the
cloning of dairy cows for insulin mass production where
the insulin, derived from a human gene and inserted in the
bovine embryo before being implanted into the mother
cow, will be released with the cow’s milk. Scientists are
hoping to have this insulin on the market within the next
couple of years (Popper 2007).
The forthcoming commercialization of genetically
engineered nutraceuticals is occurring at a time when
governments around the globe are becoming more
accepting of genetic modification. While the U.S. and
Canada have historically been supportive of the production
and consumption of genetically engineered foods,
countries in the European Union, Australia, China and
India, that traditionally opposed genetic modification, have
been slowly starting to accept certain GM products. Brazil
approved commercial sales of Syngenta’s transgenetic
corn in June (Danby 2008), although in the past there had
been violent protests against GM production. Likewise, in
South Africa farmers have been increasing production of
genetically engineered crops, by as much as 30 percent
from 2006 to 2007; in 2007 approximately 57 percent of
the total maize acreage was planted to genetically
modified maize (Conversations about Plant Biotechnology,
2008). 
Along with excitement about the market potential of
this new generation of GM products, there has also been
resistance and skepticism from those opposed to genetic
modification. A case in point involves strict regulations and
restrictions in England that recently forced scientists
working on genetically modified pig organs that could be
used for human organ transplant procedures, to move their
research from England to the U.S. (Sample 2007).
Whether consumers will embrace genetically
engineered nutraceuticals remains to be seen. On the one
hand, as the biotech sector would certainly hope, the use of
genetic modification for nutritional and medicinal
purposes, coupled with the persistence of high food prices
in national and international food markets, could make
consumers more accepting of genetically modified food
products. On the other hand, the use of agricultural
products in competing uses may be viewed as contributing
to high food prices and thus may not be welcome; this has
certainly been the case with agricultural crops used in
biofuel production. 
A second year Undergraduate Creative Activities and
Research Experience (UCARE) research project that is
currently underway in the Department of Agricultural
Economics at the University of NebraskaSLincoln, and will
be completed by June 2009, involves the development of a
survey that will be used to gather information and shed
light into consumer perceptions of genetically engineered
food products; consumer familiarity with, and attitudes
towards genetically engineered nutraceuticals; and the
potential effect of these new products on consumer
attitudes towards genetic modification. Survey participants
will be University of NebraskaSLincoln students and
consumers in the Lincoln, Nebraska area and survey results
will be published in a second year UCARE research report.
Note: The article is based on Karoline Kastanek’s first year
UCARE project “The Market Effects of Genetically
Engineered Nutraceuticals” conducted in the Department
of Agricultural Economics at the University of Nebraska-
Lincoln.
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